Image

Geriatric Nutritional Risk Index and ASA Status for Predicting Lung Complications After Major Abdominal Surgery in Older Adults

Geriatric Nutritional Risk Index and ASA Status for Predicting Lung Complications After Major Abdominal Surgery in Older Adults

Recruiting
65 years and older
All
Phase N/A

Powered by AI

Overview

Postoperative pulmonary complications (PPCs), such as pneumonia, atelectasis, and respiratory failure, are major causes of illness, prolonged hospital stays, and intensive care admissions in older patients undergoing elective major abdominal surgery. The American Society of Anesthesiologists Physical Status (ASA-PS) classification is commonly used before surgery to estimate risk. However, ASA-PS does not directly measure nutritional depletion or muscle weakness, which are critical risk factors in geriatric patients.

The Geriatric Nutritional Risk Index (GNRI) is a simple, objective screening tool calculated from preoperative serum albumin levels and body weight.

The purpose of this observational study is to evaluate the role of GNRI in predicting postoperative pulmonary complications and to determine whether adding GNRI to the standard ASA-PS classification improves the ability to identify older patients at high risk for lung complications after major abdominal surgery.

Eligibility

Inclusion Criteria:

  • Age 65 years or older.
  • Scheduled for elective major abdominal surgery under general anesthesia, including colorectal surgery, gastrectomy, pancreatic surgery, or major hepatobiliary resection.
  • American Society of Anesthesiologists Physical Status (ASA-PS) class I, II, III, or IV.
  • Informed consent provided by the participant or their legal representative.

Exclusion Criteria:

  • Emergency surgery.
  • Minor or superficial procedures that do not require major intra-abdominal surgery, such as diagnostic laparoscopy, simple laparoscopic cholecystectomy, or simple hernia repair.
  • Active pneumonia or acute respiratory failure before surgery.
  • Missing preoperative serum albumin, body weight, or height measurements.
  • Does not provide informed consent or withdraws from the study.

Study details
    Postoperative Pulmonary Complications (PPC)

NCT07862777

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

21 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.